Rose pose surgical weight loss
Advocates of the procedure say the POSE procedure may be an ideal solution for people with excess weight who have not had success with diet and exercise and who do not qualify or do not want to undergo a more extensive type of bariatric surgery. According to study results, the treatment proved safe, with no major adverse events, and led to sustained weight loss and a dramatic reduction in hunger levels. Weight loss balloons are designed to fill up space in the stomach and assist with weight loss by limiting food intake and reducing feelings of hunger. The FDA has yet to approve, but the results support the ReShape Duo as a potential new treatment option for overweight patients. It is generally an outpatient procedure (about 1 hour), with most patients making a quick return to normal activities (only a few days to a week, depending on the individual). The multiple folds of stomach tissue created by the POSE procedure effectively reduce the size and capacity of the stomach to limit food intake and diminish hunger cravings. Weight Loss Balloons Prove Successful in US Pivotal Trial. Primary Obesity Surgery Endoluminal, or POSE procedure, is an endoscopic incisionless weight loss procedure that reduces the size of the stomach and helps to diminish hunger cravings. The IOP and endoscope are passed through the mouth and into the stomach. POSE is currently considered investigational for weight loss and performed at only a few select locations around the United States. Although the method is currently under investigational status in the United States, it has been used in other parts of the world since 1997.
The study results were submitted to the US Food and Drug Administration (FDA) in July, and a decision by the FDA is expected by the middle of next year. Researchers presented findings of the pilot clinical trial, Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity), at the 2016 Annual Scientific Meeting of the Society of Interventional Radiology. A new non-surgical weight loss treatment, known as bariatric arterial embolization (BAE), could offer individuals a safe and effective alternative to weight loss surgery. To perform POSE, doctors use the Incisionless Operating Platform (IOP), a specialized set of endoscopic surgery tools developed by USGI Medical for incisionless gastrointestinal procedures, and an endoscope (flexible tube with a small camera on the end) to visualize the stomach. Researchers at the Mayo Clinic in Rochester, Minnesota have been investigating this weight loss option and have recently published the results of a second study. The POSE procedure is a type of weight loss surgery that restricts eating and reduces hunger by reducing the size and capacity of the stomach by folding and anchoring the stomach tissue. A new treatment method known as endoscopic sleeve gastroplasty is showing promise as a minimally invasive, safe and cost-effective weight loss intervention for patients with obesity. The POSE (Primary Obesity Surgery Endolumenal) incisionless weight loss procedure is safe, effective, and well-tolerated for patients with obesity, a conclusion supported once again by the results of another study. The POSE procedure is primarily designed for patients who want to lose between 25 and 60 or 70 pounds, rather than standard bariatric surgery patients who need to lose 100 pounds or more. The ReShape Duo Intragastric Balloon System can boost weight loss and improve comorbidities, safely, effectively, and with a high patient satisfaction rate, according to results of the REDUCE US Pivotal Trial. The procedure is performed entirely through the mouth and does not require any external cuts into the body.
